Newly Discovered miRNA Impacts CHO Monoclonal Antibodies
High-Throughput Intact Mass Analysis Using Parameterization
Automating MS-Based Biotherapeutic Characterization
Identification of IgG2 Disulfide Isoforms
Japan: Data Integration Platform for Precision Medicine
HT MS-based Characterization of Multispecifics at Sanofi
Analyzing Phenotypic Screening Data With Genedata Screener
Enhancing the Integration of Translational Datasets
Mass Spec-Based Analysis of Emerging Biotherapeutics
NGS for Adventitious Agent Detection
Automated Analysis of Complex Biphasic PROTAC Dose Response Data
What's New in Genedata Screener 18
Running Automated Assay Cascades in the Digital Lab
Cell Line Characterization 2.0
Genedata Imagence 3.0 Is Here! See What's New.
AI-powered HCS Analytics with Genedata Imagence 3.0
Flow Cytometry, Automated Analysis and Reporting
Automated Monitoring of Glycosylation in Biopharmaceuticals
Streamlining the Analysis of Compound Combination Screens
Interpretation of Mechanistic Screening Data
Protein Engineering: Bi- and Multi-Specifics, TCRs, and CAR Ts
Merging Automation and Data Management Technology
Integrating Automated and Manual Cell Line Development Workflows
A Single End-to-End Platform for MAM
A Novel Data Processing Strategy for Detection of Low-Abundance HCPs
Using AI for High-Content Phenotypic Characterization
Mosaic SampleBank and Genedata Screener
HT-Electrophysiology Cardiac Liability Assessment
Analyze Multiple APC Plates in One Session
HCS Analysis Workflow at Amgen
Analyze all bioassay data on one single platform
Addressing the Efficacy and Toxicity Challenges of Immuno-Oncology
Target Identification in Triple Negative Breast Cancers
Quality Monitoring of Biotherapeutics by Multi-attribute Methods
Ovarian Cancer Therapeutics using Novel Liquid Biopsy Tests
Novel Methods for Deep Characterization of Biotherapeutics
Unbiased MS-based Characterization of a Stressed mAb
LC-MS Peptide Map Profiling
